ARCTIC FRONT CRYOCATHETER SYSTEM
Medtronic Cryocath, LP · Decision date Dec 17, 2010
What did the FDA approve?
The FDA database entry for P100010 records an approval decision dated December 17, 2010, for the Arctic Front Cryocatheter System from Medtronic Cryocath, LP. The device is categorized as a percutaneous cardiac ablation catheter for treatment of atrial fibrillation under product code OAE.
The approval statement lists the indication as treatment of drug refractory recurrent symptomatic paroxysmal atrial fibrillation. The entry does not include supplement type, supplement reason, or other fields describing a changed item or original scope, so no further detail about the approval's relationship to any prior PMA is available from these fields.
FDA approval order statement
APPROVAL OF THE ARCTIC FRONT CRYOCATHETER SYSTEM. THE DEVICE IS INDICATED FOR THE TREATMENT OF DRUG REFRACTORY RECURRENT SYMPTOMATIC PAROXYSMAL ATRIAL FIBRILLATION.
- Regulatory pathway
- Original PMA
- Clinical specialty
- Cardiovascular
- Decision date
- Dec 17, 2010
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P100010
- Regulatory pathway
- Premarket approval application
- Applicant
- Medtronic Cryocath, LP
- Product code
- OAE
- Decision code
- APPR
- Decision date
- Dec 17, 2010
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation.
- Applicant
- Medtronic Cryocath, LP
- Product code
- OAE
- FDA device class
- 3
The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.
FDA decision timeline
P100010 received
Application receipt date recorded by FDA.
P100010 · FDA decision
APPR
P100010/S154 · Related supplement
STOP Persistent AF
Timeline entries are records held by MedtechLedger for P100010. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P100010
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
STOP Persistent AFP100010/S154 | Medtronic Cryocath, LP | PMA supplement | Sep 25, 2026 | FDA |
Explore the linked device profile
Other records with product code OAE
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
TactiFlex Ablation Catheter, Sensor EnabledP220013/S034 | ABBOTT MEDICAL | PMA supplement | Sep 22, 2026 | FDA |
| Biosense Webster, Inc. | PMA supplement | Sep 15, 2026 | FDA | |
QDOT MICRO SystemP210027/S018 | Biosense Webster, Inc. | PMA supplement | Sep 10, 2026 | FDA |
| ABBOTT MEDICAL | PMA supplement | Sep 4, 2026 | FDA | |
| ABBOTT MEDICAL | PMA approval | May 18, 2023 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Medtronic Cryocath, LP
- Headquarters
- Not reported
- Brand website
- medtronic.com
- FDA applicant address
- 8200 Coral Sea St., Ms Mv S46, Mounds View, MN, 55112
Sources and methodology
- Original FDA record: P100010
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records

